Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)-Reference-Cited by-同舟云学术

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

Published:2023-03 Issue: Volume:57 Page:101895
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Mastrorosa Ilaria^ORCID,Gagliardini Roberta,Segala Francesco Vladimiro^ORCID,Mondi Annalisa,Lorenzini Patrizia,Cerva Carlotta,Taddei Eleonora,Bai Francesca,Vergori Alessandra,Negri Marcantonio^ORCID,Pinnetti Carmela,Cicalini Stefania,Murri Rita,Mazzotta Valentina^ORCID,Camici Marta,Mosti Silvia,Bini Teresa,Maffongelli Gaetano,Beccacece Alessia,Milozzi Eugenia,Iannetta Marco,Lamonica Silvia,Fusto Marisa,Plazzi Maria Maddalena,Ottou Sandrine,Lichtner Miriam^ORCID,Fantoni Massimo,Andreoni Massimo,Sarmati Loredana,Cauda Roberto,Girardi Enrico,Nicastri Emanuele,D'Arminio Monforte Antonella^ORCID,Palmieri Fabrizio,Cingolani Antonella,Vaia Francesco,Antinori Andrea,Agrati Chiara,Andreoni Massimo,Antinori Andrea,Bai Francesca,Beccacece Alessia,Barreca Filippo,Bertuccio Maria Paola,Bini Teresa,Boumis Evangelo,Camici Marta,Cauda Roberto,Cerva Carlotta,Cicalini Stefania,Cingolani Antonella,D'Arminio Monforte Antonella,D'Urso Angela,De Masi Margherita,De Zottis Federico,Del Borgo Cosmo,Di Gennaro Francesco,Emiliozzi Arianna,Fantoni Massimo,Fondaco Laura,Fusto Marisa,Gagliardini Roberta,Giovannenze Francesca,Grilli Elisabetta,Iannetta Marco,Iodice Daniele,Lichtner Miriam,Lorenzini Patrizia,Maffongelli Gaetano,Masone Erminia,Massa Barbara,Mastrorosa Ilaria,Mazzotta Valentina,Mencarini Paola,Milozzi Eugenia,Mondi Annalisa,Mosti Silvia,Murri Rita,Negri Marcantonio,Nicastri Emanuele,Oliva Gian Piero,Onnelli Giovanna,Ottou Sandrine,Pace Pier Giorgio,Palmieri Fabrizio,Paulicelli Jessica,Pinnetti Carmela,Plazzi Maria Maddalena,Sarmati Loredana,Segala Francesco Vladimiro,Sorace Chiara,Taddei Eleonora,Vergori Alessandra,Vitale Pietro

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed 23 August 2022.

2. An inflammatory cytokine signature predicts COVID-19 severity and survival;Del Valle;Nat Med,2020

3. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis;Shankar-Hari;JAMA,2021

4. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway;Khan;Elife,2021

5. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial;Rosas;Intensive Care Med [Internet],2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Anti-Interleukin-6 Agents on Psychopathology in a Sample of Patients with Post-COVID-19 Syndrome: An Observational Study;Brain Sciences;2024-01-03